FDA Guidelines Targeted Children for HIV Vaccine Experiments_ Africa-AIDS Numbers Overstated_WashPos
This is an action alert to prevent the abuse of children who are sought as guinea pigs in HIV-AIDS vaccine trials!
-
-
Pfizer Faulted-1996 Clinical Trials In Nigeria: Unapproved Drug Tested On Kids_WashPost
The Washington Post reveals that a shocking secret investigative report by a Nigerian government panel of medical experts concluded that Pfizer Pharmaceuticals conducted an unethical drug experiment in Nigeria in 1996.
-
Glaxo denies “disease mongering”_Selling Bipolar questioned_PLoS
Under the influence of pharmaceutical companies, physicians anhd drug companies engage in "disease mongering." Below is a critique of Dr. David Healy’s essay: Dr. Nassir Ghaemi who argues for the legitimacy of bipolar diagnosis.
-
“Corruption & Pharmceuticals”–World Bank/ Blocking Generics–Peter Rost / WashPost
"Corruption in any one of the critical decision points in the pharmaceutical system can be detrimental to a country’s ability to improve the health of its population." [World Banki]
-
NJ: Mandatory Mental Screening Women_Pill Pushers: NO Science, Salesmanship_FORBES
Three reports illustrate the wide and deepening disconnect between medicine under the influence of pharmaceutical industry marketing goals and scientific evidence that contradicts current practice and public health policies:
-
Conflicts of interest: psychiatry’s diagnostic manual DSM-III_DSM-IV
Dr. Robert Spitzer, who has continued to play a central role in DSM revisions since 1980, claim he does not think a conflict of interest exists.
See list of APA Task Force on DSM-IV and DSM-IV Revised Text at: https://ahrp.stagenoises.ch/cms/content/view/145/27/
-
Disease Mongering_Conference / PLoS Special Issue
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
-
Red Light Districts in State Capitols_Peter Rost
The Pharmaceutical industry rakes in $500 billion globally–$230 billion in North America–57% of revenues is on marketing.
-
CATIE study results Contradict Current Clinical Practice & Treatment Guidelines
Newly published results (phase II) from the CATIE schizophrenia treatment efficacy study sponsored by the National Institute of Mental Health comparing the most commonly used second generation drug treatments for schizophrenia and depression, is highly disturbing.
-
FDA Staff Travels on Drug Industry Dollars
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
-
Are Drugs Always Needed for Schizophrenia? What does the Scientific Evidence Show?
“Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?” An article in the Schizophrenia Bulletin, by Dr. John Bola that dares to question the validity of the unexamined treatment paradigm in schizophrenia:
-
Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow
Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency.